{"slideshow_credits": null, "snippet": "Filings in a case against Bayer and Johnson & Johnson over the blood-thinning drug Xarelto said the companies helped mislead editors at The New England Journal of Medicine.", "abstract": "Suit filed by patients against Johnson & Johnson and Bayer over safety of drug Xarelto accuses pharmaceutical companies of intentionally deceiving editors of The New England Journal of Medicine by staying silent about data that was missing from letter published in journal; experts say claim recalls era in which crucial clinical data often was omitted from journal articles.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2016/03/02/business/document-claims-drug-makers-deceived-a-top-medical-journal.html", "lead_paragraph": "Filings in a case against Bayer and Johnson & Johnson over the blood-thinning drug Xarelto said the companies helped mislead editors at The New England Journal of Medicine.", "headline": {"main": "Document Claims Drug Makers Deceived a Top Medical Journal", "print_headline": "Document Claims Drug Makers Deceived a Top Medical Journal"}, "_id": "56d6423a38f0d83a4dd60e01", "word_count": "1380", "multimedia": [{"height": 126, "url": "images/2016/03/01/business/0301xareltojpg/0301xareltojpg-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/03/01/business/0301xareltojpg/0301xareltojpg-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 845, "url": "images/2016/03/01/business/0301xareltojpg/0301xareltojpg-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/01/business/0301xareltojpg/0301xareltojpg-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "845"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/03/01/business/0301xareltojpg/0301xareltojpg-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/01/business/0301xareltojpg/0301xareltojpg-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-03-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Johnson & Johnson", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Bayer AG", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "New England Journal of Medicine", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Academic and Scientific Journals", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Duke University", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Ethics and Official Misconduct", "is_major": "N", "rank": "7"}, {"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}